Establishment Labs Holdings Inc. (ESTA)
- Previous Close
34.58 - Open
35.00 - Bid 24.97 x 100
- Ask 44.80 x 200
- Day's Range
34.40 - 35.12 - 52 Week Range
26.56 - 60.12 - Volume
260,571 - Avg. Volume
616,161 - Market Cap (intraday)
1.011B - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
-- - EPS (TTM)
-3.12 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
53.71
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
www.establishmentlabs.comRecent News: ESTA
View MorePerformance Overview: ESTA
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ESTA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ESTA
View MoreValuation Measures
Market Cap
1.01B
Enterprise Value
1.17B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.87
Price/Book (mrq)
26.22
Enterprise Value/Revenue
6.86
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-52.34%
Return on Assets (ttm)
-11.43%
Return on Equity (ttm)
-186.68%
Revenue (ttm)
170.24M
Net Income Avi to Common (ttm)
-89.1M
Diluted EPS (ttm)
-3.12
Balance Sheet and Cash Flow
Total Cash (mrq)
69.18M
Total Debt/Equity (mrq)
585.48%
Levered Free Cash Flow (ttm)
-44.94M